Korea Investment CORP Purchases Shares of 84,605 Astera Labs, Inc. $ALAB

Korea Investment CORP acquired a new position in Astera Labs, Inc. (NASDAQ:ALAB) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 84,605 shares of the company’s stock, valued at approximately $40,866,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of ALAB. BlackRock Inc. bought a new stake in shares of Astera Labs in the second quarter valued at approximately $6,609,581,000. Atreides Management LP raised its stake in Astera Labs by 108.9% during the 1st quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock valued at $368,890,000 after purchasing an additional 1,754,593 shares during the last quarter. Amundi raised its stake in Astera Labs by 1,298.6% during the 3rd quarter. Amundi now owns 1,421,263 shares of the company’s stock valued at $278,283,000 after purchasing an additional 1,319,643 shares during the last quarter. Artisan Partners Limited Partnership acquired a new position in Astera Labs during the 4th quarter valued at $148,980,000. Finally, Goldman Sachs Group Inc. boosted its holdings in Astera Labs by 189.0% in the 4th quarter. Goldman Sachs Group Inc. now owns 1,312,927 shares of the company’s stock valued at $218,419,000 after purchasing an additional 858,693 shares during the period. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In related news, Director Jack R. Lazar sold 10,000 shares of the company’s stock in a transaction on Thursday, June 4th. The shares were sold at an average price of $355.17, for a total value of $3,551,700.00. Following the completion of the transaction, the director directly owned 75,688 shares of the company’s stock, valued at approximately $26,882,106.96. This represents a 11.67% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 90,630 shares of the company’s stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $340.35, for a total value of $30,845,920.50. Following the transaction, the chief executive officer directly owned 1,266,665 shares of the company’s stock, valued at $431,109,432.75. This represents a 6.68% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last quarter, insiders sold 419,244 shares of company stock valued at $163,135,169. Company insiders own 10.40% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on the company. Bank of America lifted their price objective on Astera Labs from $240.00 to $450.00 and gave the stock a “neutral” rating in a report on Tuesday, June 23rd. Barclays raised their target price on Astera Labs from $200.00 to $325.00 and gave the stock an “equal weight” rating in a research report on Monday, July 20th. TD Cowen decreased their price target on shares of Astera Labs from $425.00 to $375.00 and set a “hold” rating on the stock in a research note on Wednesday, August 5th. Needham & Company LLC boosted their price target on shares of Astera Labs from $260.00 to $425.00 and gave the company a “buy” rating in a report on Wednesday, August 5th. Finally, Roth Capital restated a “buy” rating and issued a $450.00 price objective on shares of Astera Labs in a research note on Wednesday, August 5th. One research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and eight have assigned a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $333.00.

Astera Labs Price Performance

Shares of Astera Labs stock opened at $284.97 on Friday. The firm has a 50 day simple moving average of $352.70 and a 200 day simple moving average of $244.92. Astera Labs, Inc. has a fifty-two week low of $97.89 and a fifty-two week high of $499.48. The firm has a market cap of $49.44 billion, a P/E ratio of 141.07 and a beta of 3.84.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, topping the consensus estimate of $0.69 by $0.11. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The firm had revenue of $392.40 million during the quarter, compared to analysts’ expectations of $360.85 million. During the same period in the previous year, the business posted $0.44 EPS. The company’s quarterly revenue was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, sell-side analysts expect that Astera Labs, Inc. will post 2.7 EPS for the current year.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.